A position paper on the diagnosis of aspirin hypersensitivity by a team of European scientists from the Global Allergy and Asthma European Network (GA2LEN) has just been published on the Allergy Journal website. Designed for health professionals, the guidelines propose detailed protocols for challenge tests. The paper is endorsed by the European Academy of Allergology and Clinical Immunology (EAACI) and GA2LEN partners.
Most people tolerate aspirin very well. For others, however, aspirin and other non-steroidal anti-inflammatory drugs trigger allergy-like asthma, sinusitis or urticaria. Reactions can be as violent and life-threatening as asthma attacks and anaphylaxis.
Hypersensitivity to aspirin has been observed since early 20th century. Today, it is one of the most common adverse reactions to a medicinal product. It is however largely under-diagnosed.
A challenge test is the only way to identify aspirin sensitivity. The patient is administered small doses of aspirin that are regularly increased, under direct supervision of a physician in a clinical environment. Hypersensitivity to aspirin is recognised when the patient’s lung function is depressed by more than 20%.
“We hope this position paper will enable physicians to proceed with diagnosis,” concludes Prof. Szczeklik, the main author of the paper. A long list of non-steroidal, anti-inflammatory drugs for common indications, such as headache, is contraindicated to hypersensitive patients. “A proper diagnosis will have a real benefit for them as they will be directed by their doctors to alternative medication that are completely safe to take, without any side-effect.”
While at least 0.5% of the general population is known to suffer from aspirin sensitivity, asthmatics are especially likely to be affected. According to a recent study, about 20% of asthmatic adults are hypersensitive to aspirin.
Related stories:
Best use of drug-eluting stents
Compared with bare metal stents, drug-eluting stents substantially reduce the risk of angiographic and clinical recurrence but do not affect mortality or the short term or long term risk of myocardial infarction. The use of drug-eluting stents necessitates extended treatment with dual antiplatelet therapy (aspirin plus thienopyridine) which may cause bleeding complications and interferes with or even precludes surgery in case this is needed.
Are blood thinners post-op killers?
Current US guidelines for the prescription of potent anticoagulants by surgeons who perform joint replacement operations could be doing patients more harm than good, according to Dr. Nigel Sharrock and his team from the Hospital for Special Surgery in New York. They argue for a revision of the American College of Chest Physicians’ guidelines, in light of their review showing that the use of powerful anticoagulants to prevent pulmonary embolism may actually lead to more deaths among patients who take these drugs. The paper was published in the March issue of Springer’s journal
Clinical Orthopaedics and Related Research.
Many stroke, heart attack patients may not benefit from aspirin
Up to 20 percent of patients taking aspirin to lower the risk of suffering a second cerebrovascular event do not have an antiplatelet response from aspirin, the effect thought to produce the protective effect, researchers at the University at Buffalo have shown.
Quick treatment following minor stroke reduces risk of major stroke by 80 per cent
Treating patients immediately after a minor stroke reduces the early risk of a major stroke by 80 per cent, Oxford research has found.
Agent that triggers immune response in plants is uncovered
Although plants lack humans' T cells and other immune-function cells to signal and fight infection, scientists have known for more than 100 years that plants still somehow signal that they have been attacked in order to trigger a plantwide resistance. Now, researchers at the Boyce Thompson Institute for Plant Research (BTI) on the Cornell campus have identified the elusive signal in the process: methyl salicylate, an aspirin-like compound that alerts a plant's immune system to shift into high gear.
What's in your microcapsule? Tattoo ink -- and more
In her Brown University laboratory, Edith Mathiowitz makes tiny particles coated in polymers. These microcapsules, some as small as the point of a pin, can carry medicines, genes, paints, pesticides – any molecule that needs protection or controlled release.
Extra pay does not improve hospital performance
Paying hospitals extra money does not appear to significantly improve the way they treat heart attack patients or how well those patients do. But giving hospitals the information that they need to improve heart attack care does help.
Aspirin may be less effective heart treatment for women than men
A new study shows that aspirin therapy for coronary artery disease is four times more likely to be ineffective in women compared to men with the same medical history.